FDA Inspection
BAYER PHARMA, AGBAYER PHARMA, AG – FDA Inspection, Jul 3, 2017
Record Details
This FDA Inspection record concerns BAYER PHARMA, AG, with an inspection on July 3, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 4cad4b59-7cd0-472e-b6f8-749df0c15721
Inspection Facts
- Inspection number
- 1023408
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of BAYER PHARMA, AG
9| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 27, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BAYER PHARMA, AG
- FDA Inspection 1282736 - 2024-06-06
- FDA Inspection 1239178 - 2021-08-27
- FDA Inspection 1102816 - 2019-09-24
- FDA Inspection 1001127 - 2017-01-24
- FDA Inspection 889209 - 2014-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.